28-003 · EVIDENCE B · SOURCE-SENSITIVE
Facial fillers should avoid the bridge of the nose, glabellar area, and forehead — and never opt for unregulated clinics just to save money.
面部填充避开鼻背、眉间、额头这几个部位,更别为省钱找非正规注射
No cost at all. You simply choose a different injection site, or skip the treatment altogether.
Between 2015 and 2018, 48 new cases of partial or total vision loss following filler injections were reported worldwide. The nose was the most common site of complications, accounting for 56.3% of cases; followed by the glabellar area at 27.1%, the forehead at 18.8%, and the nasolabial fold at 14.6%. Hyaluronic acid was used in over 80% of these cases. Only 20.8% of patients regained full vision, while 16.7% saw partial recovery; the rest remained visually impaired. Nearly 20% also developed complications affecting the central nervous system. Currently, no single treatment has been proven consistently effective for reversing these effects, so prevention remains the only reliable option.
B
Move “Facial fillers should avoid the bridge of the nose, glabellar area, and forehead — and never opt for unregulated clinics just to save money.” to Future Me's calendar
The excuse
Future Me has a clearer calendar, more patience, and apparently the same responsibilities.
What feels good now
Today I keep a few minutes and avoid interrupting my default routine.
What the source says
The source summarizes the return this way: “Between 2015 and 2018, 48 new cases of partial or total vision loss following filler injections were reported worldwide. The nose was the most common site of complications, accounting for 56.3% of cases; followed by the glabellar area at 27.1%, the forehead at 18.8%, and the nasolabial fold at 14.6%. Hyaluronic acid was used in over 80% of these cases. Only 20.8% of patients regained full vision, while 16.7% saw partial recovery; the rest remained visually impaired. Nearly 20% also developed complications affecting the central nervous system. Currently, no single treatment has been proven consistently effective for reversing these effects, so prevention remains the only reliable option.” Evidence grade B. The original states the population, caveats, and sources; this is not a personal forecast.
Use the original facts and limits. For an urgent medical, safety, financial, or legal issue, contact a qualified local professional or service.
THE ENGLISH EDITION
Original recommendation and evidence
3. Facial fillers should avoid the bridge of the nose, glabellar area, and forehead — and never opt for unregulated clinics just to save money.
Cost: No cost at all. You simply choose a different injection site, or skip the treatment altogether.
In plain terms: Between 2015 and 2018, 48 new cases of partial or total vision loss following filler injections were reported worldwide. The nose was the most common site of complications, accounting for 56.3% of cases; followed by the glabellar area at 27.1%, the forehead at 18.8%, and the nasolabial fold at 14.6%. Hyaluronic acid was used in over 80% of these cases. Only 20.8% of patients regained full vision, while 16.7% saw partial recovery; the rest remained visually impaired. Nearly 20% also developed complications affecting the central nervous system. Currently, no single treatment has been proven consistently effective for reversing these effects, so prevention remains the only reliable option.
Benefit: Data compiled from all published case reports worldwide show that from January 2015 through September 2018, 48 new instances of partial or complete vision loss occurred after filler injections. The nasal region accounted for 56.3% of incidents, followed by the glabellar area at 27.1%, the forehead at 18.8%, and the nasolabial fold at 14.6%. Hyaluronic acid was identified as the filler material in 81.3% of cases. Skin changes appeared in 43.8% of patients, while central nervous system complications arose in 18.8%. Ten patients (20.8%) fully recovered vision, eight (16.7%) partially recovered, and the remainder did not improve. Researchers concluded that treatment approaches varied widely across studies, and no single method has been demonstrated to reliably restore vision.
Evidence grade: B
Sources: Beleznay K et al. (2019). Update on Avoiding and Treating Blindness From Fillers: A Recent Review of the World Literature. Aesthet Surg J. <https://doi.org/10.1093/asj/sjz053>
Notes: These figures were derived by manually tallying each reported case across medical journals. They reflect only the number of patients experiencing complications, not the total number of injections performed; thus it is impossible to calculate the exact probability of blindness per injection. The B rating reflects this limitation. Reputable clinics naturally employ standard risk‑minimization practices: mapping vascular pathways beneath the injection sites, using blunt‑tip needles instead of sharp ones, administering small amounts of filler while slowly withdrawing the needle, and keeping hyaluronidase on hand. All these steps must be carried out by trained physicians — which is precisely why unregulated providers should be avoided. Before proceeding, verify that the clinic holds proper licensing and that the attending physician is qualified, as outlined in Section 2 of this chapter.
Read the complete Chinese source and notes
3. 面部填充避开鼻背、眉间、额头这几个部位,更别为省钱找非正规注射
成本: 不花钱。只是换个部位打,或者不做。
说人话: 打填充针后失明的人里,一半多打的是鼻部,其次是眉间、额头和法令纹,八成多用的是玻尿酸。失明的人只有两成视力完全恢复,一成多部分恢复,将近两成还伤到了脑。目前没有一种抢救办法稳定管用,只能事先避开这些部位。
收益: 把全世界期刊报过的病例汇总起来算。2015 年 1 月到 2018 年 9 月新增 48 例注射填充后部分或完全视力丧失。出事最多的部位是鼻部,占 56.3%。接下来是眉间 27.1%、前额 18.8%、鼻唇沟(法令纹那道沟)14.6%。81.3% 的病例填充物为透明质酸,就是玻尿酸。43.8% 出现皮肤改变。18.8% 出现中枢神经系统并发症(脑出了问题)。10 例(20.8%)视力完全恢复,8 例(16.7%)部分恢复,剩下的没恢复。作者结论为各家的处理方式差得很远,没有一种治疗被证明能持续奏效
证据等级: B
来源: Beleznay K et al. (2019). Update on Avoiding and Treating Blindness From Fillers: A Recent Review of the World Literature. Aesthet Surg J. <https://doi.org/10.1093/asj/sjz053>
备注: 这些数字是把期刊报过的病例一例一例数出来的。里面只有出事的人数,没有打针的总人数。所以算不出「打一针有多大概率失明」,只看得出哪些部位出事多、事后基本救不回来。证据记 B 级也是因为这个。正规机构降低风险的做法本来就是常规:先查清要打的地方底下血管怎么走,用钝头针不用尖针,边退针边少量推,事先备好透明质酸酶。每一样都要求动手的是受过训练的医生,这也是别找非正规渠道的理由。做之前先按本节第 2 条(查机构许可证和主诊医师)核一遍。
YOUR PRIVATE LIST